Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection (Q44801102)
Jump to navigation
Jump to search
scientific article published in November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection |
scientific article published in November 2008 |
Statements
1 reference
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection (English)
1 reference
1 reference
1 reference
Stefan Zeuzem
1 reference
Tobias Goeser
1 reference
Holger Hinrichsen
1 reference
Michael von Wagner
1 reference
Wolf Peter Hofmann
1 reference
Gerlinde Teuber
1 reference
Ulrich Spengler
1 reference
Hans Weidenbach
1 reference
Michael Manns
1 reference
Peter Buggisch
1 reference
Eva Herrmann
1 reference
1 November 2008
1 reference
1 reference
48
1 reference
5
1 reference
1404-1411
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference